• Home >>
  • Pharmaceuticals and Healthcare >>
  • Glucose Monitor Devices Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Glucose Monitor Devices Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 185112 April, 2018 Region : Global Pages Reports Monitor

Global glucose monitor devices market, by type (invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices and others), application (type 1 diabetes, type 2 diabetes and others), end user (home care diagnostic, diagnostic centre, hospitals, clinics and research centres) forecast till 2025


Market Scenario

Diabetes is a condition characterised by increased blood sugar level for longer period of time. Glucose monitoring devices are equipment which tests the glucose level in the blood. Monitoring glucose level in the body helps to manage diabetes and efficiency of medication. Rising prevalence of the diabetes globally increases the demand of the glucose monitor device results in growth of the market. Regular monitoring of glucose level in blood attributed to efficient treatment to the diabetes. Increasing awareness of the product and its significance plays vital role in the development of the market. Rising R & D expenditure and technological advancement propel the glucose monitoring market.


Growing healthcare infrastructure and disposal income in developing economies are boosting the market. Availability of different product type achieved customer compliance. The cost of the glucose testing with this device is low compared to the point of sample test. Accuracy in the reading is one of the major factors restraining the growth of the market. At a time of glucose level measurement, devices represent single reading at single point in time which can hamper the market. Stringent government regulation for approval of the devices is one of the biggest challenge for the players in this market.    



Segmentation

The global glucose monitor device market is segmented on the basis of type, application and end user.

On the basis of type, the market is segmented as invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices and others.

On the basis of application, the market is segmented as type 1 diabetes, type 2 diabetes and others.

On the basis of end user, the market is segmented as home care diagnostic, diagnostic centre, hospitals, clinics and research centres.


Regional Analysis

By geography, this market is studied with respect to four major regions North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific is lucrative market for the glucose monitor devices market owing rising population, disposal income and healthcare infrastructure. Increasing prevalence of diabetes in North America due to presence of higher number of geriatric population led to the higher usage of devices. 



Key Players

The key players in the market are: Becton, Dickinson and Co., Terumo Corporation, Acon Laboratories Inc., Roche Diagnostics Ltd., Johnson & Johnson, ARKRAY Inc., Novo Nordisk A/S, Medtronic, Abbott Laboratories, Bayer AG, Ypsomed AG and Sanofi.


Segmentation

By Type:

• Invasive Glucose Monitoring Devices 

• Continuous Glucose Monitoring Devices (CGM) 

• Flash Glucose Monitoring Devices 

• Others


By Application:

• Type 1 Diabetes

• Type 2 Diabetes 

• Others


By End User:

• North America

• Europe

• Asia-Pacific

• LAMEA

Research Scope


 

The study for Global Glucose Monitoring Market will provide market size, estimates and forecast based on the following years: 

 

Historic data: 2015  Base Year Estimate: 2016  Forecast: 2017 to 2025

The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 

Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 

The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 

 

1. Introduction

1.1. Market Definition

1.2. Market Scope


2. Research Methodology

2.1. Primary Research

2.2. Secondary Sources

2.3. Assumptions & Exclusions


3. Market Overview

3.1. Research Report Segmentation & Scope

3.2. Key Market Trend Analysis

3.2.1. Market Drivers

3.2.2. Market Restraint/Challenges

3.2.3. Market Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Potential Venture Avenues

3.5. Market Share Analysis, 2016 

3.6. Market Overview


4. Type Overview

4.1. Introduction

4.2. Market Size & Forecast, 2015 to 2025

4.2.1. Invasive Glucose Monitoring Devices 

4.2.2. Continuous Glucose Monitoring Devices (CGM) 

4.2.3. Flash Glucose Monitoring Devices 

4.2.4. Others

 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)

5. Application Overview

5.1. Introduction

5.2. Market Size & Forecast, 2015 to 2025

5.2.1. Type 1 Diabetes

5.2.2. Type 2 Diabetes 

5.2.3. Others

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. End User

6.1. Introduction

6.2. Market Size & Forecast, 2015 to 2025


7. North America

7.1.1. Europe

7.1.2. Asia-Pacific

7.1.3. LAMEA

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


8. Regional Overview

8.1. Introduction

8.2. Market Size & Forecast, 2015 to 2025

8.2.1. North America

8.2.1.1. U.S.

8.2.1.2. Canada

8.2.1.3. Mexico 

8.2.2. Europe

8.2.2.1. UK

8.2.2.2. Germany

8.2.2.3. France

8.2.2.4. Italy 

8.2.2.5. Spain

8.2.2.6. Rest of Europe

8.2.3. Asia-Pacific

8.2.3.1. China

8.2.3.2. India

8.2.3.3. Japan

8.2.3.4. South Korea

8.2.3.5. Rest of Asia-Pacific

8.2.4. LAMEA

8.2.4.1. Brazil

8.2.4.2. UAE

8.2.4.3. South Africa

8.2.4.4. Rest of LAMEA

(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


9. Manufacturer/ Vendor Profile

9.1. The following attributes will be considered while profiling key manufacturers in this industry: 

9.1.1. Company Overview

9.1.2. Financial Synopsis

9.1.3. Recent Developments

9.1.4. R&D Investments (if any)

9.1.5. Strategy Overview (Analyst Perspective)

9.1.6. Product Portfolio

9.2. Companies Profiled

9.2.1. Dickinson and Co.

9.2.2. Terumo Corporation 

9.2.3. Acon Laboratories Inc.

9.2.4. Roche Diagnostics Ltd.

9.2.5. Johnson & Johnson 

9.2.6. ARKRAY Inc.

9.2.7. Novo Nordisk A/S 

9.2.8. Medtronic 

9.2.9. Abbott Laboratories 

9.2.10. Bayer AG 

9.2.11. Ypsomed AG

(Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.) 

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]